AXQ Capital’s Amgen AMGN Stock Holding History

AXQ Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,355	Closed	-$353K	–	489
2024 Q4	$353K	Buy	+1,355	New	+$402K	0.16%	229
2023 Q3	–	Sell	-1,900	Closed	-$422K	–	459
2023 Q2	$422K	Sell	1,900 -5,300	-74%	-$1.23M	0.52%	57
2023 Q1	$1.74M	Buy	+7,200	New	+$1.77M	0.69%	20

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AXQ Capital's AMGN Position: Q1 2025 in Review

AXQ Capital sold out of Amgen (AMGN) in Q1 2025, closing a stake of 1,355 shares — an estimated $353K sold.

AXQ Capital first reported a position in AMGN in Q1 2023 and held it in 3 quarters. The position peaked at $1.74M in Q1 2023. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

AXQ Capital reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
AXQ Capital sold 1,355 Amgen shares in Q1 2025, an estimated $353K.
AXQ Capital first reported a position in Amgen in Q1 2023 and held it in 3 quarters.
AXQ Capital's Amgen position peaked at $1.74M in Q1 2023.
2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on AXQ Capital's 13F filing for Q1 2025, filed 13 May 2025.